NewsHealth / April 25, 2016

Community Hospital East To Offer New Melanoma Treatment

Community Hospital East To Offer New Melanoma Treatment

INDIANAPOLIS (AP) — An Indianapolis hospital will begin treating melanoma patients with a new drug that uses a modified virus to infiltrate and destroy deadly skin cancer tumors.

Community Hospital East says it will soon start treating patients with the injectable drug from Amgen Inc. for patients with hard-to-treat melanoma.

The drug, Imlygic, is injected directly into tumor tissue, where it uses the herpes virus as a Trojan horse to slip past and rupture cancer cells. It also creates an anti-tumor response in patient's immune system.

The virus is modified so that it only replicates within cancer cells, while leaving healthy cells alone.

This immunotherapy drug was approved late last year by the Food and Drug Administration.

At WFYI, our goal is to cover stories that matter to you. Our reporting is rooted in facts. It considers all perspectives and is available to everyone. We don't have paywalls, but we do need support. So if unbiased, trusted journalism is important to you, please join us. Donate now.

 

 

Related News

Health Officials Warn West Nile Virus Has Been Found In Indiana Mosquitoes
Updates On COVID-19 In Indiana: Health Department Adds 1,046 Cases, 20 Deaths To State's Totals
Nearly Half Of Indiana's Nursing Homes Report At Least One Case Of COVID-19